Skip to main content
Top
Published in: Arthritis Research & Therapy 3/2014

Open Access 01-06-2014 | Research article

Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis

Authors: Kwi Young Kang, In Je Kim, Seung Min Jung, Seung-Ki Kwok, Ji Hyeon Ju, Kyung-Su Park, Yeon Sik Hong, Sung-Hwan Park

Published in: Arthritis Research & Therapy | Issue 3/2014

Login to get access

Abstract

Introduction

Ankylosing spondylitis (AS) is associated with an increased incidence of vertebral fractures (VFs); however the actual incidence and predictors of morphometric VFs are unknown. The present study examined the incidence and predictors of new VFs in a large AS cohort.

Methods

In total, 298 AS patients who fulfilled the modified New York criteria were enrolled and spinal radiographs were evaluated biennially. Clinical and laboratory data and radiographic progression were assessed according to the Bath AS Disease Activity Index, erythrocyte sedimentation rate, C-reactive protein (CRP), and the Stoke AS spine score (SASSS). VF was defined according to the Genant criteria. The incidence of VFs at 2 and 4 years was evaluated using the Kaplan-Meier method. The age-specific standardized prevalence ratio (SPR) for AS patients in comparison with the general population was calculated.

Results

Of 298 patients, 31 (10.8%) had previous VFs at baseline. A total of 30 new VFs occurred in 26 patients over 4 years. The incidence of morphometric VFs was 4.7% at 2 years and 13.6% at 4 years. Multivariate logistic regression analysis showed that previous VFs at baseline and increased CRP levels at 2 years were predictors of new VFs (odds ratio (OR) =12.8, 95% confidence interval (CI) = 3.6-45.3 and OR = 5.4, 95% CI = 1.4–15.9). The age-specific specific standardized prevalence ratio of morphometric VFs in AS was 3.3 (95% CI 2.1–4.5).

Conclusions

The incidence of morphometric VFs increased in AS. Previous VFs and increased CRP levels predicted future VFs. Further studies are needed to identify the effects of treatment interventions on the prevention of new VFs.
Appendix
Available only for authorised users
Literature
2.
go back to reference Jun JB, Joo KB, Her MY, Kim TH, Bae SC, Yoo DH, Kim SK: Femoral bone mineral density is associated with vertebral fractures in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol. 2006, 33: 1637-1641.PubMed Jun JB, Joo KB, Her MY, Kim TH, Bae SC, Yoo DH, Kim SK: Femoral bone mineral density is associated with vertebral fractures in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol. 2006, 33: 1637-1641.PubMed
3.
go back to reference Montala N, Juanola X, Collantes E, Munoz-Gomariz E, Gonzalez C, Gratacos J, Zarco P, Fernandez Sueiro JL, Mulero J, Torre-Alonso JC, Batlle E, Carmona L: Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis. J Rheumatol. 2011, 38: 893-897.CrossRefPubMed Montala N, Juanola X, Collantes E, Munoz-Gomariz E, Gonzalez C, Gratacos J, Zarco P, Fernandez Sueiro JL, Mulero J, Torre-Alonso JC, Batlle E, Carmona L: Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis. J Rheumatol. 2011, 38: 893-897.CrossRefPubMed
4.
go back to reference Davey-Ranasinghe N, Deodhar A: Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr Opin Rheumatol. 2013, 25: 509-516.CrossRefPubMed Davey-Ranasinghe N, Deodhar A: Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr Opin Rheumatol. 2013, 25: 509-516.CrossRefPubMed
5.
go back to reference Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L, Bezza A, El Maghraoui A: Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone. 2009, 44: 772-776.CrossRefPubMed Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L, Bezza A, El Maghraoui A: Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone. 2009, 44: 772-776.CrossRefPubMed
6.
go back to reference Cooper C, Carbone L, Michet CJ, Atkinson EJ, O’Fallon WM, Melton LJ: Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol. 1994, 21: 1877-1882.PubMed Cooper C, Carbone L, Michet CJ, Atkinson EJ, O’Fallon WM, Melton LJ: Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol. 1994, 21: 1877-1882.PubMed
7.
go back to reference Klingberg E, Geijer M, Gothlin J, Mellstrom D, Lorentzon M, Hilme E, Hedberg M, Carlsten H, Forsblad-D’Elia H: Vertebral fractures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skeleton. J Rheumatol. 2012, 39: 1987-1995.CrossRefPubMed Klingberg E, Geijer M, Gothlin J, Mellstrom D, Lorentzon M, Hilme E, Hedberg M, Carlsten H, Forsblad-D’Elia H: Vertebral fractures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skeleton. J Rheumatol. 2012, 39: 1987-1995.CrossRefPubMed
8.
go back to reference van der Weijden MA, van der Horst-Bruinsma IE, van Denderen JC, Dijkmans BA, Heymans MW, Lems WF: High frequency of vertebral fractures in early spondylarthropathies. Osteoporos Int. 2012, 23: 1683-1690.CrossRefPubMed van der Weijden MA, van der Horst-Bruinsma IE, van Denderen JC, Dijkmans BA, Heymans MW, Lems WF: High frequency of vertebral fractures in early spondylarthropathies. Osteoporos Int. 2012, 23: 1683-1690.CrossRefPubMed
9.
go back to reference Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ: Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res. 1992, 7: 221-227.CrossRefPubMed Cooper C, Atkinson EJ, O’Fallon WM, Melton LJ: Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res. 1992, 7: 221-227.CrossRefPubMed
10.
go back to reference Vosse D, Landewe R, van der Heijde D, van der Linden S, van Staa TP, Geusens P: Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case–control study. Ann Rheum Dis. 2009, 68: 1839-1842.CrossRefPubMed Vosse D, Landewe R, van der Heijde D, van der Linden S, van Staa TP, Geusens P: Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case–control study. Ann Rheum Dis. 2009, 68: 1839-1842.CrossRefPubMed
11.
go back to reference Pasco JA, Henry MJ, Korn S, Nicholson GC, Kotowicz MA: Morphometric vertebral fractures of the lower thoracic and lumbar spine, physical function and quality of life in men. Osteoporosis Int. 2009, 20: 787-792.CrossRef Pasco JA, Henry MJ, Korn S, Nicholson GC, Kotowicz MA: Morphometric vertebral fractures of the lower thoracic and lumbar spine, physical function and quality of life in men. Osteoporosis Int. 2009, 20: 787-792.CrossRef
13.
go back to reference van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27: 361-368.CrossRefPubMed van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27: 361-368.CrossRefPubMed
14.
go back to reference Genant HK, Wu CY, van Kuijk C, Nevitt MC: Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993, 8: 1137-1148.CrossRefPubMed Genant HK, Wu CY, van Kuijk C, Nevitt MC: Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993, 8: 1137-1148.CrossRefPubMed
15.
go back to reference Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT: Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol. 1996, 35: 373-376.CrossRefPubMed Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT: Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol. 1996, 35: 373-376.CrossRefPubMed
16.
go back to reference Shin CS, Kim MJ, Shim SM, Kim JT, Yu SH, Koo BK, Cho HY, Choi HJ, Cho SW, Kim SW, Kim SY, Yang SO, Cho NH: The prevalence and risk factors of vertebral fractures in Korea. J Bone Miner Metab. 2012, 30: 183-192.CrossRefPubMed Shin CS, Kim MJ, Shim SM, Kim JT, Yu SH, Koo BK, Cho HY, Choi HJ, Cho SW, Kim SW, Kim SY, Yang SO, Cho NH: The prevalence and risk factors of vertebral fractures in Korea. J Bone Miner Metab. 2012, 30: 183-192.CrossRefPubMed
17.
go back to reference Geusens P, Vosse D, van der Linden S: Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr Opin Rheumatol. 2007, 19: 335-339.CrossRefPubMed Geusens P, Vosse D, van der Linden S: Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr Opin Rheumatol. 2007, 19: 335-339.CrossRefPubMed
18.
go back to reference Vasdev V, Bhakuni D, Garg MK, Narayanan K, Jain R, Chadha D: Bone mineral density in young males with ankylosing spondylitis. Int J Rheum Dis. 2011, 14: 68-73.CrossRefPubMed Vasdev V, Bhakuni D, Garg MK, Narayanan K, Jain R, Chadha D: Bone mineral density in young males with ankylosing spondylitis. Int J Rheum Dis. 2011, 14: 68-73.CrossRefPubMed
19.
20.
go back to reference Redlich K, Smolen JS: Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 2012, 11: 234-250.CrossRefPubMed Redlich K, Smolen JS: Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 2012, 11: 234-250.CrossRefPubMed
21.
go back to reference Feldtkeller E, Vosse D, Geusens P, van der Linden S: Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis. Rheumatol Int. 2006, 26: 234-239.CrossRefPubMed Feldtkeller E, Vosse D, Geusens P, van der Linden S: Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis. Rheumatol Int. 2006, 26: 234-239.CrossRefPubMed
22.
go back to reference McCloskey EV, Vasireddy S, Threlkeld J, Eastaugh J, Parry A, Bonnet N, Beneton M, Kanis JA, Charlesworth D: Vertebral fracture assessment (VFA) with a densitometer predicts future fractures in elderly women unselected for osteoporosis. J Bone Miner Res. 2008, 23: 1561-1568.CrossRefPubMed McCloskey EV, Vasireddy S, Threlkeld J, Eastaugh J, Parry A, Bonnet N, Beneton M, Kanis JA, Charlesworth D: Vertebral fracture assessment (VFA) with a densitometer predicts future fractures in elderly women unselected for osteoporosis. J Bone Miner Res. 2008, 23: 1561-1568.CrossRefPubMed
23.
go back to reference Briggs AM, Greig AM, Wark JD: The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis. Osteoporosis Int. 2007, 18: 575-584.CrossRef Briggs AM, Greig AM, Wark JD: The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis. Osteoporosis Int. 2007, 18: 575-584.CrossRef
24.
go back to reference Gehlbach S, Saag KG, Adachi JD, Hooven FH, Flahive J, Boonen S, Chapurlat RD, Compston JE, Cooper C, Diez-Perez A, Greenspan SL, LaCroix AZ, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Sambrook PN, Silverman S, Siris ES, Watts NB, Lindsay R: Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res. 2012, 27: 645-653.CrossRefPubMed Gehlbach S, Saag KG, Adachi JD, Hooven FH, Flahive J, Boonen S, Chapurlat RD, Compston JE, Cooper C, Diez-Perez A, Greenspan SL, LaCroix AZ, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Sambrook PN, Silverman S, Siris ES, Watts NB, Lindsay R: Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res. 2012, 27: 645-653.CrossRefPubMed
25.
go back to reference El Maghraoui A, Rezqi A, Mounach A, Achemlal L, Bezza A, Ghozlani I: Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment. Rheumatology (Oxford). 2010, 49: 1303-1310.CrossRef El Maghraoui A, Rezqi A, Mounach A, Achemlal L, Bezza A, Ghozlani I: Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment. Rheumatology (Oxford). 2010, 49: 1303-1310.CrossRef
26.
go back to reference Kang KY, Lee KY, Kwok SK, Ju JH, Park KS, Hong YS, Kim HY, Park SH: The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis. Joint Bone Spine. 2011, 78: 188-193.CrossRefPubMed Kang KY, Lee KY, Kwok SK, Ju JH, Park KS, Hong YS, Kim HY, Park SH: The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis. Joint Bone Spine. 2011, 78: 188-193.CrossRefPubMed
27.
go back to reference Kang KY, Ju JH, Park SH, Kim HY: The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis. Rheumatology (Oxford). 2013, 52: 718-726.CrossRef Kang KY, Ju JH, Park SH, Kim HY: The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis. Rheumatology (Oxford). 2013, 52: 718-726.CrossRef
28.
go back to reference Vastesaeger N, van der Heijde D, Inman RD, Wang Y, Deodhar A, Hsu B, Rahman MU, Dijkmans B, Geusens P, Vander Cruyssen B, Collantes E, Sieper J, Braun J: Predicting the outcome of ankylosing spondylitis therapy. Ann Rheum Dis. 2011, 70: 973-981.PubMedCentralCrossRefPubMed Vastesaeger N, van der Heijde D, Inman RD, Wang Y, Deodhar A, Hsu B, Rahman MU, Dijkmans B, Geusens P, Vander Cruyssen B, Collantes E, Sieper J, Braun J: Predicting the outcome of ankylosing spondylitis therapy. Ann Rheum Dis. 2011, 70: 973-981.PubMedCentralCrossRefPubMed
29.
go back to reference Gratacos J, Collado A, Pons F, Osaba M, Sanmarti R, Roque M, Larrosa M, Munoz-Gomez J: Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum. 1999, 42: 2319-2324.CrossRefPubMed Gratacos J, Collado A, Pons F, Osaba M, Sanmarti R, Roque M, Larrosa M, Munoz-Gomez J: Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum. 1999, 42: 2319-2324.CrossRefPubMed
30.
go back to reference Eriksson AL, Moverare-Skrtic S, Ljunggren O, Karlsson M, Mellstrom D, Ohlsson C: High sensitive CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: The MrOS Sweden study. J Bone Miner Res. 2014, 29: 418-423.PubMedCentralCrossRefPubMed Eriksson AL, Moverare-Skrtic S, Ljunggren O, Karlsson M, Mellstrom D, Ohlsson C: High sensitive CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: The MrOS Sweden study. J Bone Miner Res. 2014, 29: 418-423.PubMedCentralCrossRefPubMed
31.
go back to reference Nakamura K, Saito T, Kobayashi R, Oshiki R, Oyama M, Nishiwaki T, Nashimoto M, Tsuchiya Y: C-reactive protein predicts incident fracture in community-dwelling elderly Japanese women: the Muramatsu study. Osteoporosis Int. 2011, 22: 2145-2150.CrossRef Nakamura K, Saito T, Kobayashi R, Oshiki R, Oyama M, Nishiwaki T, Nashimoto M, Tsuchiya Y: C-reactive protein predicts incident fracture in community-dwelling elderly Japanese women: the Muramatsu study. Osteoporosis Int. 2011, 22: 2145-2150.CrossRef
32.
go back to reference Ishii S, Cauley JA, Greendale GA, Crandall CJ, Danielson ME, Ouchi Y, Karlamangla AS: C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women’s Health Across the Nation (SWAN). J Bone Miner Res. 2013, 28: 1688-1698.CrossRefPubMed Ishii S, Cauley JA, Greendale GA, Crandall CJ, Danielson ME, Ouchi Y, Karlamangla AS: C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women’s Health Across the Nation (SWAN). J Bone Miner Res. 2013, 28: 1688-1698.CrossRefPubMed
33.
go back to reference Vosse D, van der Heijde D, Landewe R, Geusens P, Mielants H, Dougados M, van der Linden S: Determinants of hyperkyphosis in patients with ankylosing spondylitis. Ann Rheum Dis. 2006, 65: 770-774.PubMedCentralCrossRefPubMed Vosse D, van der Heijde D, Landewe R, Geusens P, Mielants H, Dougados M, van der Linden S: Determinants of hyperkyphosis in patients with ankylosing spondylitis. Ann Rheum Dis. 2006, 65: 770-774.PubMedCentralCrossRefPubMed
34.
go back to reference Davis JC, van der Heijde DM, Braun J, Dougados M, Clegg DO, Kivitz AJ, Fleischmann RM, Inman RD, Ni L, Lin SL, Tsuji WH: Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis. Ann Rheum Dis. 2008, 67: 346-352.CrossRefPubMed Davis JC, van der Heijde DM, Braun J, Dougados M, Clegg DO, Kivitz AJ, Fleischmann RM, Inman RD, Ni L, Lin SL, Tsuji WH: Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis. Ann Rheum Dis. 2008, 67: 346-352.CrossRefPubMed
35.
go back to reference Lambert RG, Salonen D, Rahman P, Inman RD, Wong RL, Einstein SG, Thomson GT, Beaulieu A, Choquette D, Maksymowych WP: Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2007, 56: 4005-4014.CrossRefPubMed Lambert RG, Salonen D, Rahman P, Inman RD, Wong RL, Einstein SG, Thomson GT, Beaulieu A, Choquette D, Maksymowych WP: Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2007, 56: 4005-4014.CrossRefPubMed
36.
go back to reference Wanders A, Heijde D, Landewe R, Behier JM, Calin A, Olivieri I, Zeidler H, Dougados M: Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005, 52: 1756-1765.CrossRefPubMed Wanders A, Heijde D, Landewe R, Behier JM, Calin A, Olivieri I, Zeidler H, Dougados M: Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005, 52: 1756-1765.CrossRefPubMed
38.
go back to reference Poddubnyy D, Haibel H, Listing J, Marker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M: Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum. 2012, 64: 1388-1398.CrossRefPubMed Poddubnyy D, Haibel H, Listing J, Marker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M: Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum. 2012, 64: 1388-1398.CrossRefPubMed
Metadata
Title
Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis
Authors
Kwi Young Kang
In Je Kim
Seung Min Jung
Seung-Ki Kwok
Ji Hyeon Ju
Kyung-Su Park
Yeon Sik Hong
Sung-Hwan Park
Publication date
01-06-2014
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 3/2014
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4581

Other articles of this Issue 3/2014

Arthritis Research & Therapy 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.